Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...

Life's instructions are written in DNA, but it is the enzyme RNA polymerase II (Pol II) that reads the script, transcribing ...

Sweat patches may one day be the status quo for medical tests ranging from glucose monitoring to drug detection. In A ...

By Kelly Peters,Special to Rice NewsAs artificial intelligence plays an increasingly prominent role in decoding DNA, tracking ...

The most promising practical applications and benefits of AI technologies might be their ability to automatically adapt to ...

The Global Bio Preservation Market presents growth opportunities driven by the rising demand for organ transplants and ...

A pair of research projects involving the Medical University of Vienna ( MedUni Vienna) and partners has now developed a new way to locate microplastics within tissue in a non-destructive and ...

Innovative studies in diagnostic applications of artificial intelligence will be presented at the Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo, taking place Nov. 11–15 in ...

Abby Stylianou built an app that asks its users to upload photos of hotel rooms they stay in when they travel. It may seem ...

GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published in The ...

While AI’s potential in healthcare is vast, its most significant impact is in medical imaging. The ROBO Global Healthcare ...